Active · per the CBE, 18 September 2026

EG

BE0419806694

Rechtspersoon Public limited company 2 establishments

EG is registered with the CBE as active in: Groothandel in farmaceutische producten. Public Limited, started on 2 October 1979, 2 establishments.

Esplanade S/N box B22, 1020 Brussel

Active for

46 year, 11 months

Financials

Financial year 2025

EG from Brussel, company number BE0419806694, closed financial year 2025 with a result of € 29.6 million after tax. For that financial year EG recorded revenue of € 263.2 million and equity of € 61.3 million. Compared with financial year 2024, the result moved from € 31.8 million to € 29.6 million. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2026.

What it is worth Healthy

€ 61.3 million

▼ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 29.6 million

▼ 7% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 43.9 million

▼ 23% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 31 million paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

162

▼ 0.5 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 24.1 million

▲ 1% vs 2024

€ 149,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 255,395

▼ 24% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 1.9 million

▲ 36% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 38.1 million

▼ 9% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 76 days on average.

Taxes and wages

€ 7 million

▼ 26% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Revenue € 240,910,079 € 252,060,382 € 262,280,216 € 263,150,627
Profit after taxes € 28,715,454 € 32,143,911 € 31,788,487 € 29,612,090 ▼ 7%
Equity € 58,765,024 € 62,908,935 € 62,697,423 € 61,309,512 ▼ 2%
Total debts € 64,378,470 € 58,477,712 € 55,267,862 € 52,252,542 ▼ 5%
Cash € 68,752,196 € 67,350,772 € 57,358,651 € 43,927,333 ▼ 23%
Retained profit € 34,282,743 € 38,426,654 € 38,215,141 € 36,827,231 ▼ 4%
Dividend € 26,000,000 € 28,000,000 € 32,000,000 € 31,000,000 ▼ 3%
Bank debt € 3,255,868 € 570,208 € 1,425,397 € 1,933,169 ▲ 36%
Balance sheet total € 123,294,821 € 121,536,647 € 117,965,285 € 113,562,055 ▼ 4%
Employees (FTE) 161.5 169.7 162.5 162 ▼ 0.5

Key figures of EG, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to EG?

What happened at EG in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Lieve Pattyn stepped down as director. NBB
  • Ole Wendler-Pedersen stepped down as director. NBB
  • New annual accounts for financial year 2025: profit of € 29.6 million (▼ 7% vs 2024). filed late Source: NBB ↗
  • Daniel Buschmann stepped down as director. NBB
  • Ole Wendler-Pedersen became a director. NBB
  • Cigdem Erek stepped down as director. NBB
  • Daniel Buschmann became a director. NBB
  • Holger Buschmann stepped down as director. NBB

In short

From € 28.7 million profit in 2022 to € 29.6 million profit in 2025.

Paid € 42.7 million in corporate taxes since 2022.

Best year ever: 2023, with € 32.1 million profit.

Paid out € 117 million in dividends to the owners in total.

Management

Directors

According to the 2025 annual accounts

Jef Hus

Managing director

Also active at: FeBelGen, Moveco

since 2017 · until 2025

Holger Buschmann

Director

since 2022 · until 2025

Cigdem Erek

Director

since 2025 · until 2025

Lieve Pattyn

Managing director

since 2025 · until 2027

Daniel Buschmann

Director

since 2025 · until 2026

Ole Wendler-Pedersen

Director

since 2026 · until 2027

Establishments

Establishment units

Physical locations of this company

Registered office

Esplanade S/N box B22

1020 Brussel

2.360.443.926

Boechoutlaan 103 box 1.02

1853 Grimbergen

Active since 1 September 2024

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0419.806.694
VAT number
BE 0419.806.694
Registered office
Esplanade S/N bus B22, 1020 Brussel
Names & denominations
EG · Eurogenerics
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
2 October 1979
Peppol
Active · Active since 1 Jan 2001
Activities · NACE

Groothandel in farmaceutische producten

Groothandel in farmaceutische en medische artikelen

Frequently asked questions

What does EG do?
EG is registered with the CBE as active in: Groothandel in farmaceutische producten. Public Limited, started on 2 October 1979, 2 establishments.
What is the address of EG?
The registered office of EG is located at Esplanade S/N box B22, 1020 Brussel.
Is EG still active?
Yes. According to the CBE (18 September 2026) EG is active, legal situation “Normale toestand”, started on 2 October 1979.
Is EG registered on Peppol?
Yes, EG is registered on the Peppol network with ID 0208:0419806694.
What is the enterprise number of EG?
The enterprise number of EG is BE0419806694.
When was EG founded?
EG was founded on 2 October 1979.